Preliminary investigation of AU-011 Related Modulight products and Services Related Publications Virus-Like Particle-Drug Conjugates Induce Protective, Long-lasting Adaptive Antitumor Immunity in the Absence of Specifically Targeted Tumor Antigens Rhonda C. Kines, Cynthia D. Thompson, Sean Spring, Zhenyu Li, Elisabet de los Pinos, Stephen Monks and John T. Schiller Cancer Immunology Research, 2021, 9 (6) A Phase 1b/2 Open-label Clinical Trial to Evaluate the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma Prithvi Mruthyunjaya, Amy C. Schefler, Ivana K.
Continue reading →Customer case Aura Biosciences, headquartered in Cambridge, MA, is developing a new class of photoactivated therapy for cancer patients together with National Cancer Institute, Emory Eye Center and Wills Eye Hospital. The therapy is based on virus-like conjugates and its primary indication is uveal melanoma. The goal is to eventually develop this technology for multiple cancer indications, such as non-muscle invasive bladder cancer (NMIBC), for which plans are underway to conduct a clinical trial. Dr. Carol Shields, MD – Aura Biosciences Dr. Rhonda Kines, PhD –
Continue reading →
BRIDGEWATER, N.J., December 04, 2018 – Bausch + Lomb, a leading global eye health company, and Modulight, Inc., a designer and manufacturer of lasers and optics for personalized medicine, announced the companies have entered into an exclusive agreement to collaborate and develop a new photodynamic laser specifically designed for use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) therapy. “Photodynamic therapy continues to be an important option for eye care professionals who treat choroidal neovascularization in patients who suffer from persistent disease activity, but the availability of lasers capable
Continue reading →
Time: Wed 15.6.2016, 8:30–11:00 Place: Hotel Kämp, Helsinki Paavo Nurmi cabinet Pohjoisesplanadi 29, Helsinki, Finland Confirmed speakers Lecture slideshows Click here to view our previous workshop at ASLMS-2015. Related products: ML7710 – the tool for professionals » | Products for oncology » | ML8500 automatic illumination system » | Illumination kit »Time: Wed 15.6.2016, 8:30–11:00 Place: Hotel Kämp, Helsinki Paavo Nurmi cabinet Pohjoisesplanadi 29, Helsinki, Finland Confirmed speakers Prof. Eero Mervaala: Optogenetics in cardiology and cardiotoxicity Professor, Pharmacology, University of Helsinki Professor Mervaala works in the field of cardiovascular and metabolic pharmacology in the Department of Pharmacology, University of Helsinki, Finland. Prof. Teuvo Tammela: Prostate cancer therapy with laser as part of combinatory treatment Professor in Urology, Tampere University Dr. Teuvo Tammela is a specialist in urology and surgery. He is a meritorious scientist especially
Continue reading →
There is no excerpt because this is a protected post.Fri 24th April 6 pm, Gaylord Palms Resort, Kissimmee, FL Topics PDT dosimetry – Dr. Gal Shafirstein, Roswell Park Cancer Center, Buffalo, NY [embeddoc url="https://modulight.com/wp-content/uploads/2015/08/ASMLS-2015-PDT-Workshop-Prof.-Shafirstein-Final.pptx" width="280px" height="210px" download="all" viewer="microsoft"] Head & Neck – Dr. Merrill Biel, University of Minnesota Medical School, Minneapolis, MN Cholangiocarsinoma & Esophageal – Dr. Herbert C. Wolfsen, Mayo Clinic, Jacksonville, FL [embeddoc url="https://modulight.com/wp-content/uploads/2015/08/ASLMS_2015_Jones-Wolfsen.pptx" width="280px" height="210px" download="all" viewer="microsoft] Thoracic PDT – Dr. Patrick Ross Jr, The Ohio State University, Columbus, OH Mesothelioma – Dr. Keith Cengel, Perelman School of Medicine, Philadelphia, PA Breast – Dr.
Continue reading →
Tampere, January 28, 2015 – Modulight, Inc., a leading biomedical laser manufacturer announced today ML7710 laser platform launch and certification. Unlike other lasers in the industry Modulight ML7710 has been certified and supports a wide range of indications and configurations. Medical CE and ETL marking are valid for all multi-channel (1–8 outputs) laser configurations between 400–2000nm and up to 15W vs. typical application and wavelength specific support. ML7710 supports directly several laser based treatment modalities, like photodynamic therapy (PDT), laser surgery, photo disinfection, and photo coagulation. This saves
Continue reading →
Sat 7th Feb 5.30–9 pm Downtown San Francisco Topics • Discuss possible ways for enhancing the dissemination of PDT for cancer therapy – Prof. Gal Shafirstein, Roswell Park CI • Scope of active clinical studies in PDT – Prof. Keith Cengel, Univ. of Pennsylvania • Diagnosis, fluorescence and spectroscopy – Prof. Brian Pogue, Dartmouth College • Is dose planning enough or should we use online treatment monitoring? – Prof. Timothy Zhu, Univ. of Pennsylvania • Will multiple channel and/or multiple wavelength lasers make our life easier? – Dr. Timothy Baran,
Continue reading →Sat 7th Feb 5.30–9 pm Downtown San Francisco Topics • Discuss possible ways for enhancing the dissemination of PDT for cancer therapy – Prof. Gal Shafirstein, Roswell Park CI • Scope of active clinical studies in PDT – Prof. Keith Cengel, Univ. of Pennsylvania • Diagnosis, fluorescence and spectroscopy – Prof. Brian Pogue, Dartmouth College • Is dose planning enough or should we use online treatment monitoring? – Prof. Timothy Zhu, Univ. of Pennsylvania • Will multiple channel and/or multiple wavelength lasers make our life easier? – Dr. Timothy Baran,
Continue reading →
Fri 24th April 6 pm, Gaylord Palms Resort, Kissimmee, FL Workshop presentations Products and accessories on display • ML7710 – CE and ETL marked multi-purpose PDT laser platform • ML6700 – PDT-Illumination laser module tailored to PDT for R&D • ML6600 – Multi-wavelength laser module for PDT • External dose calibration module for PDT lasers NEW • Hand pieces for superficial PDT illumination NEW • Tailored PC software for PDT laser modules Speakers’ biographies Click here to view our previous workshop at PW-2015. Related products: ML7710 – the tool for professionals » |
Continue reading →Fri 24th April 6 pm, Gaylord Palms Resort, Kissimmee, FL Workshop presentations PDT dosimetry – Dr. Gal Shafirstein, Roswell Park Cancer Center, Buffalo, NY [embeddoc url=”https://modulight.com/wp-content/uploads/2015/08/ASMLS-2015-PDT-Workshop-Prof.-Shafirstein-Final.pptx” width=”280px” height=”210px” download=”all” viewer=”microsoft”] Head & Neck – Dr. Merrill Biel, University of Minnesota Medical School, Minneapolis, MN Cholangiocarsinoma & Esophageal – Dr. Herbert C. Wolfsen, Mayo Clinic, Jacksonville, FL [embeddoc url=”https://modulight.com/wp-content/uploads/2015/08/ASLMS_2015_Jones-Wolfsen.pptx” width=”280px” height=”210px” download=”all” viewer=”microsoft] Thoracic PDT – Dr. Patrick Ross Jr, The Ohio State University, Columbus, OH Mesothelioma – Dr. Keith Cengel, Perelman School of Medicine, Philadelphia, PA Breast –
Continue reading → 
